ArticleBritish journal of clinical pharmacology2018

The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling.

Ida Netterberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.